Both companies work through retail pharmacy, but are also extending services to point-of-care and direct-to-patient
InVentiv Health (Marlborough, MA) is buying the Catalina Health subsidiary of Catalina, a major direct-marketing firm, for an undisclosed price; the acquisition will be combined with inVentiv’s Adheris unit to form what the company calls “the nation’s largest provider of tailored, direct-to-patient medication adherence programs.” Renee Selman, president of Catalina Health, will become president of the combined business, which itself is part of another inVentiv grouping called inVentiv Health Patient Outcomes.
Mark Dmytruk, president of Patient Outcomes, explains that traditionally, Adheris has managed mail, telephone and messaging refill-reminder services for major retail pharmacy chains; some 20,000 pharmacies are part of its network. Catalina Health also has relationships with pharmacy chains, but has a proprietary platform to insert reminder messaging in patient receipts and other communications. Adheris has also been extending its franchise in recent months with the selection of a mobile-communications vendor, CellepaticRx, that provides HIPAA-compliant direct-to-patient communications services for healthcare providers. Of equal interest, Adheris has been working with Dr. First, a leading electronic health-records (EHR) company, and Epocrates, a popular drug-information resource (now owned by athenahealth, another EHR vendor) to connect adherence program information with physicians’ workflows at the point of care. Messaging from pharma to doctors through EHR systems is a new channel of communications with high potential for pharma marketers.
“Over the past year, we’ve seen growing client demand for coordinated patient messaging and an increased focus on patient-centric outcome strategies,” says Dmytruk, noting its importance in the Medicare Star program for rating healthcare systems, and the “meaningful use” incentives that are part of HHS’ program to encourage EHR use. “The acquisition improves our ability to deliver exactly what our clients need.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.